R&D Systems™ Recombinant Human TGF-beta 1 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by its ability to inhibit the IL-4-dependent proliferation of HT-2 mouse T cells. Tsang, M. et al. (1995) Cytokine 7:389. The ED50 for this effect is 0.04-0.2 ng/mL.

Spécification

• Formule: Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.
• Identification génétique (Entrez): 7040
• Poids moléculaire: 12.8 kDa (monomer)
• Nom: TGF-beta 1
• Quantité: 10 μg
• Source: Chinese Hamster Ovary cell line,CHO-derived human TGF-beta 1 protein Ala279-Ser390
• Conditions de stockage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Forme structurelle: Disulfide-linked homodimer
• Alias de gène: CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1
• Conjugué: Unconjugated
• Recombinant: Recombinant
• Pureté ou qualité: 97%, by SDS-PAGE with silver staining.